DENTSPLY SIRONA (XRAY) Set to Announce Earnings on Thursday

DENTSPLY SIRONA (NASDAQ:XRAY) is scheduled to issue its quarterly earnings data before the market opens on Thursday, May 6th. Analysts expect the company to announce earnings of $0.55 per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Sunday, February 28th. The medical instruments supplier reported $0.87 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.64 by $0.23. DENTSPLY SIRONA had a negative net margin of 1.40% and a positive return on equity of 7.13%. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $997.38 million. During the same period last year, the firm earned $0.73 earnings per share. The company’s quarterly revenue was down 2.6% on a year-over-year basis. On average, analysts expect DENTSPLY SIRONA to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

NASDAQ XRAY opened at $68.95 on Wednesday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.38 and a current ratio of 3.10. The firm’s 50 day moving average price is $64.24 and its 200-day moving average price is $56.12. DENTSPLY SIRONA has a 52-week low of $36.12 and a 52-week high of $69.01. The company has a market cap of $15.04 billion, a PE ratio of -299.78, a P/E/G ratio of 5.06 and a beta of 0.98.

The company also recently announced a quarterly dividend, which was paid on Friday, April 9th. Shareholders of record on Friday, March 26th were paid a $0.10 dividend. The ex-dividend date was Thursday, March 25th. This represents a $0.40 annualized dividend and a yield of 0.58%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 16.33%.

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 5,000 shares of DENTSPLY SIRONA stock in a transaction that occurred on Thursday, March 4th. The stock was purchased at an average price of $58.95 per share, with a total value of $294,750.00. Following the completion of the acquisition, the director now directly owns 13,850 shares in the company, valued at approximately $816,457.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Eric Brandt sold 7,600 shares of the firm’s stock in a transaction on Wednesday, March 17th. The stock was sold at an average price of $63.21, for a total transaction of $480,396.00. Following the transaction, the director now directly owns 38,131 shares of the company’s stock, valued at approximately $2,410,260.51. The disclosure for this sale can be found here. Insiders own 0.53% of the company’s stock.

Several equities research analysts have weighed in on XRAY shares. Robert W. Baird raised their target price on shares of DENTSPLY SIRONA from $62.00 to $71.00 and gave the company an “outperform” rating in a research note on Tuesday, March 2nd. HC Wainwright restated a “neutral” rating and issued a $60.00 target price (up from $55.00) on shares of DENTSPLY SIRONA in a research note on Tuesday, March 2nd. Barclays raised their target price on shares of DENTSPLY SIRONA from $50.00 to $55.00 and gave the company an “underweight” rating in a research note on Tuesday, March 2nd. Piper Sandler raised their target price on shares of DENTSPLY SIRONA from $63.00 to $70.00 and gave the company an “overweight” rating in a research note on Monday, March 1st. Finally, Barrington Research upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $71.00 target price for the company in a research note on Monday, March 8th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $55.08.


DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Further Reading: The role of implied volatility with call option volume


Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with's FREE daily email newsletter.